Showing results (641-650 of 889) with videos related to

Sort By:
Pageof 89
Drugs in R&D|September 4, 2024
Pharmacokinetics, Mass Balance, and Biotransformation of [14C]tinengotinib, A Novel Multi-target Kinase Inhibitor, in Healthy SubjectsShumao Ni, Sheng Ma, Yingying Yu, et al.
Drugs in R&D|September 4, 2024
Comparative Analytical Evaluation of the Proposed Biosimilar FYB206 and its Reference Medicinal Product Keytruda®Jakob C Stüber, Kerstin Uhland, Alwin Reiter, et al.
Drugs in R&D|June 14, 2024
Efficacy of Co-Crystal of Tramadol-Celecoxib (CTC) in Patients with Acute Moderate-to-Severe Pain: A Pooled Analysis of Data from Two Phase 3 Randomized Clinical TrialsRichard Langford, Eugene R Viscusi, Adelaida Morte, et al.
Drugs in R&D|May 29, 2024
Pharmacokinetics and Bioequivalence of Two Formulations of Azithromycin Tablets: A Randomized, Single-Dose, Three-Period, Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed ConditionsYingrong Chen, Libing Ye, Jue Mei, et al.
Drugs in R&D|December 8, 2025
Multiple-Dose Up-Titration Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Omecamtiv Mecarbil in Healthy Chinese SubjectsXuening Li, Hui Li, Hongrong Xu, et al.
Drugs in R&D|December 11, 2025
Omadacycline Pharmacokinetics: Characteristics, Contributing Factors, and Clinical SignificanceHuan Sun, Xiaoli Hou, Qiuzhen Zhu, et al.
Drugs in R&D|January 10, 2024
Real-World Experience of Carglumic Acid for Methylmalonic and Propionic Acidurias: An Interim Analysis of the Multicentre Observational PROTECT StudySufin Yap, Delphine Lamireau, Francois Feillet, et al.
Drugs in R&D|September 24, 2024
Clinical Assessment of Breast Cancer Resistance Protein (BCRP)-Mediated Drug-Drug Interactions of Sepiapterin with Curcumin and Rosuvastatin in Healthy VolunteersLan Gao, Diksha Kaushik, Kimberly Ingalls, et al.
Drugs in R&D|November 20, 2023
Unveiling the Influence of a High-Fat Meal on the Pharmacokinetics of Oral Globalagliatin, A Glucokinase Activator, in Healthy Chinese VolunteersMaodi Xu, Yaqin Wang, Xiaohu Wang, et al.
Drugs in R&D|November 8, 2023
A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use DisorderJames C Miller, Michael A Brooks, Kelly E Wurzel, et al.
Pageof 89